Sotera Health Announces New Secondary Offering
Sotera Health Company (Nasdaq: SHC) has recently made an exciting announcement for its stakeholders about a significant secondary offering of 25 million shares of its common stock, each valued at $0.01. This offering is being led by prominent affiliates Warburg Pincus LLC and GTCR LLC, who are the selling shareholders in this transaction. It's important to note that the company itself will not be selling any shares or receiving any proceeds from this offering.
Offering Details
According to the terms of the offering, the selling stockholders will experience a change in control, as they will no longer hold a majority of Sotera Health’s outstanding shares. This shift is expected to impact certain sponsor rights linked to these holdings, which are elaborated in the most recent general meeting proxy statement filed by the company. Although affiliates like Warburg Pincus and GTCR will be decreasing their stakes, this strategy aims to improve market liquidity.
Citigroup as Underwriter
Citigroup has taken on the role of underwriter for this important offering. They plan to distribute the shares across various platforms, including Nasdaq and the over-the-counter market. This strategy ensures that the shares will be available at market or negotiated prices, providing flexible options for buyers interested in participating in this offering.
How to Access the Prospectus
For those interested in more information about this offering, Sotera Health has announced that a prospectus will be made available. Interested parties can request copies from Citigroup, specifically through Broadridge Financial Solutions, located in New York. This transparency allows potential investors to access essential details and terms related to the offering.
SEC Registration Information
To comply with regulatory requirements, a registration statement for these securities has already been filed with the Securities and Exchange Commission. This statement was submitted in February 2024 and has since taken effect automatically, facilitating a smooth process for the offering to move forward without any issues.
Understanding Forward-Looking Statements
When discussing the offering, it's crucial to understand that some statements made are categorized as 'forward-looking statements.' While these statements express optimism about the future of the business, they also come with inherent risks and uncertainties. Potential investors are encouraged to review these risks as outlined in the company’s latest annual report and SEC filings to make informed decisions.
About Sotera Health
Sotera Health is recognized as a leading global provider, offering essential end-to-end sterilization solutions along with comprehensive lab testing and advisory services tailored for the healthcare sector. The company's operations are organized into three primary divisions: Sterigenics, Nordion, and Nelson Labs. With a strong commitment to their mission, "Safeguarding Global Health," Sotera Health aims to support healthcare providers and enhance safety and efficacy within the industry.
Investor Relations and Media Contacts
For any inquiries related to investor relations, Jason Peterson, the Vice President, is available at the company's office and can be reached at IR@soterahealth.com. For media inquiries, Kristin Gibbs, the Chief Marketing Officer, is the designated contact and can also be reached at kgibbs@soterahealth.com.
Frequently Asked Questions
What is Sotera Health's secondary offering about?
Sotera Health announced a secondary offering of 25 million shares led by its affiliates, which is expected to change the control of majority shares.
Who is responsible for underwriting the offering?
Citigroup is acting as the underwriter, facilitating the sale of shares through various platforms.
Will Sotera Health receive any proceeds from the offering?
No, the company will not receive any funds from this secondary offering; all proceeds will go to the selling stockholders.
Where can I find more information about the offering?
Information will be provided in a prospectus available through Citigroup's Broadridge Financial Solutions.
What does the term 'forward-looking statements' mean?
This term refers to statements that discuss future projections or expectations, which may involve risks and uncertainties.
